Redeye updates its estimates and valuation after Lifco’s Q4 2025 report.
Redeye provides its initial take on Lifco’s Q4 2025 report, which missed our projections by 3% on sales and 5% on EBITA.
Redeye updates its estimates and valuation after Lifco’s Q3 2025 report.
Redeye provides its initial take on Lifco’s Q3 2025 report, which aligned with our estimates.
Redeye nudges down its estimates and valuation following Lifco’s Q2 2025 report.
Redeye provides its initial take on Lifco’s Q2 2025 report, which came in below our estimates.
Redeye updates its estimates and valuation following Lifco releasing its Q1 2025 report.
Redeye provides its initial take on Lifco’s Q1 2025 report, which came in roughly in line with our estimates.
Redeye updates its estimates and valuation following Lifco releasing its Q4 2024 report.
Redeye provides its initial take on Lifco’s Q4 2024 report, which featured a slight sales beat and margins that roughly aligned with our est...
Redeye updates its estimates and valuation following Lifco releasing its Q3 2024 report.
Redeye provides its initial take on Lifco’s Q3 2024 report, which broadly aligned with our estimates.
Redeye updates its estimates and valuation following Lifco releasing its Q2 2024 report.
Redeye provides its initial take on Lifco’s Q2 2024 report, which came in broadly above our estimates.
Redeye updates its estimates and valuation following Lifco releasing its Q1 2024 report, which came in broadly below our estimates.
Redeye provides its initial take on Lifco’s Q1 2024 report, which came in broadly below our estimates.
Redeye updates its estimates and valuation following Lifco’s Q4 2023 report.
Redeye provides its initial take on Lifco’s Q4 2023 report, which came in slightly below our estimates.
Redeye initiates coverage of Lifco, an increasingly sector-agnostic serial acquirer.
